Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes-Reference-Cited by-同舟云学术

Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes

Published:2014-02 Issue:2 Volume:25 Page:384-391
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Masuda H.,Brewer T.M.,Liu D.D.,Iwamoto T.,Shen Y.,Hsu L.,Willey J.S.,Gonzalez-Angulo A.M.,Chavez-MacGregor M.,Fouad T.M.,Woodward W.A.,Reuben J.M.,Valero V.,Alvarez R.H.,Hortobagyi G.N.,Ueno N.T.

Funder

the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic and a State of Texas Rare and Aggressive Breast Cancer Research Program

National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/2/384/16699100/mdt525.pdf

Reference15 articles.

1. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment;Dawood;Ann Oncol,2011

2. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute;Hance;J Natl Cancer Inst,2005

3. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990–2008;Schlichting;Breast Cancer Res Treat,2012

4. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study;Dawood;Cancer,2011

5. Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer;Li;Oncologist,2011

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Strategies for Locally Advanced Breast Cancer: A Review of Inflammatory Breast Cancer and Nonresponders;Clinical Breast Cancer;2024-06

2. Prolonged survival in a patient with metastatic HER2-positive inflammatory breast cancer: A case report;Asian Journal of Surgery;2024-06

3. A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer;Cancer Research;2024-03-20

4. TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer;Breast Cancer Research;2024-01-31

5. Bilateral inflammatory recurrence of HER-2 positive breast cancer: a unique case report and literature review;Frontiers in Oncology;2024-01-12